[1]
“A Review on the Therapeutic Targeting of the Gut Microbiome for the Mitigation of Type 2 Diabetes Mellitus: Review article”, JOPIR, vol. 4, no. 3, pp. 099–116, Jun. 2026, doi: 10.69613/7rzc7r52.